? ?Medetomidine Hydrochloride (CAS 86347-15-1) | High-Purity Veterinary Anesthetic & Pharmaceutical Intermediate? ?

?? ?Product Overview?

?Medetomidine Hydrochloride? (CAS 86347-15-1) is a potent ?α2-adrenoceptor agonist? with the molecular formula ?C??H??ClN?? and a molecular weight of ?236.74?. This white to off-white crystalline powder (purity ≥99%) is primarily used in ?veterinary medicine? for sedation, analgesia, and as a key intermediate in active pharmaceutical ingredient (API) synthesis. Its rapid onset and reversible effects make it ideal for animal surgical procedures and diagnostic imaging.

?Key Functions?:

• Induces safe sedation in companion and livestock animals.

• Reduces stress during veterinary procedures.

• Serves as a critical intermediate for dexmedetomidine synthesis.

?Target Industries?: Veterinary pharmaceuticals, API manufacturing, and research.

? ?Key Advantages?

?? ?Applications?

• ?Veterinary Surgery?

  : Pre-anesthetic sedation for dogs, cats, and horses.

• ?API Production?

  : Intermediate for dexmedetomidine HCl and related α2-agonists.

• ?Research?

  : Used in neuropharmacology studies and anesthesia protocols.

?? ?Quality Assurance?

• ?Certifications?

  : Complies with ISO 9001 and veterinary pharmacopeial standards.

• ?Testing?

  : Rigorous HPLC, NMR, and mass spectrometry validation.

• ?Storage?

  : Maintain integrity in sealed, light-protected containers.

?? ?Market Insights?

The global veterinary anesthesia market is projected to grow at ?5.8% CAGR (2025-2030)?, driven by increasing pet healthcare expenditure and livestock management needs. Medetomidine demand is rising in emerging markets, with ?China? leading API production due to cost-effective manufacturing capabilities.